7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
      
    		                  
      revenues:
    		                  
      medical services revenue
    		1,432,437,000 1,392,039,000 1,529,879,000 1,519,244,000 1,447,697,000 1,479,579,000 1,601,195,000 813,344,000 1,212,132,000 1,134,830,000 688,855,000 693,934,000 669,184,000 652,423,000 461,999,000 457,646,000 497,678,000 412,412,000 
      other operating revenue
    		2,884,000 2,943,000 2,903,000 3,242,000 3,235,000 3,179,000 3,159,000 2,160,000 3,528,000 1,317,000 919,000 924,000 950,000 1,022,000 887,000 967,000 1,278,000 692,000 
      total revenues
    		1,435,321,000 1,394,982,000 1,532,782,000 1,522,486,000 1,450,932,000 1,482,758,000 1,604,354,000 815,504,000 1,215,660,000 1,136,147,000 689,774,000 694,858,000 670,134,000 653,445,000 462,886,000 458,613,000 498,956,000 413,104,000 
      yoy
    		-1.08% -5.92% -4.46% 86.69% 19.35% 30.51% 132.59% 17.36% 81.41% 73.87% 49.02% 51.51% 34.31% 58.18%     
      qoq
    		2.89% -8.99% 0.68% 4.93% -2.15% -7.58% 96.73% -32.92% 7.00% 64.71% -0.73% 3.69% 2.55% 41.17% 0.93% -8.09% 20.78%  
      expenses:
    		                  
      medical services expense
    		1,489,479,000 1,445,245,000 1,401,867,000 1,518,678,000 1,505,950,000 1,374,060,000 1,443,842,000 922,702,000 1,104,396,000 972,827,000 628,163,000 618,287,000 587,140,000 566,208,000 430,620,000 414,202,000 442,483,000 360,354,000 
      other medical expenses
    		13,488,000 2,164,000 80,193,000 42,063,000 9,149,000 76,523,000 85,424,000 -11,902,000 80,787,000 86,024,000 51,615,000 50,659,000 49,080,000 44,773,000 22,678,000 29,454,000 33,694,000 23,661,000 
      general and administrative
    		56,198,000 56,281,000 65,956,000 59,755,000 63,123,000 69,612,000 76,422,000 63,277,000 74,138,000 66,846,000 75,207,000 51,980,000 51,924,000 39,834,000 341,820,000 34,683,000 43,013,000 37,777,000 
      depreciation and amortization
    		7,430,000 7,319,000 6,876,000 6,494,000 6,218,000 5,907,000 5,844,000 1,029,000 5,310,000 4,189,000 3,907,000 3,450,000 3,042,000 3,373,000 3,621,000 3,915,000 3,581,000 3,427,000 
      total expenses
    		1,566,595,000 1,511,009,000 1,554,892,000 1,630,586,000 1,584,440,000 1,526,102,000 1,611,532,000 975,106,000 1,264,631,000 1,129,886,000 758,892,000 724,376,000 691,186,000 654,188,000 510,759,000 494,214,000 797,319,000 425,219,000 
      income from operations
    		-131,274,000 -116,027,000 -22,110,000 -108,100,000 -133,508,000 -43,344,000 -7,178,000 -159,602,000 -48,971,000 6,261,000 -69,118,000 -29,518,000 -21,052,000 -743,000 -47,873,000 -35,601,000 -298,363,000 -12,115,000 
      yoy
    		-1.67% 167.69% 208.02% -32.27% 172.63% -792.29% -89.61% 440.69% 132.62% -942.66% 44.38% -17.09% -92.94% -93.87%     
      qoq
    		13.14% 424.77% -79.55% -19.03% 208.02% 503.85% -95.50% 225.91% -882.16% -109.06% 134.16% 40.21% 2733.38% -98.45% 34.47% -88.07% 2362.76%  
      operating margin %
    		-9.15% -8.32% -1.44% -7.10% -9.20% -2.92% -0.45% -19.57% -4.03% 0.55% -10.02% -4.25% -3.14% -0.11% -10.34% -7.76% -59.80% -2.93% 
      other income:
    		                  
      income from equity method investments
    		13,133,000 5,412,000 12,672,000 -2,694,000 2,047,000 9,955,000 5,684,000 -8,018,000 14,659,000          
      other income
    		9,441,000 7,879,000 9,261,000 7,695,000 16,061,000 4,841,000 5,892,000 6,839,000 5,690,000 9,472,000 14,885,000 574,000 6,997,000 2,269,000 -8,534,000 -269,000 2,967,000 1,336,000 
      interest expense
    		-1,838,000 -1,572,000 -1,515,000 -1,574,000 -1,622,000 -1,697,000 -1,284,000 -1,886,000 -1,651,000 -1,533,000 -1,709,000 -1,000,000 -945,000 -871,000 -840,000 -867,000 -1,498,000 -2,941,000 
      income before income taxes
    		-110,538,000 -104,308,000 -1,692,000 -104,673,000 -117,022,000 -30,245,000 3,114,000 -162,667,000 -30,273,000 14,200,000 -55,942,000 -29,944,000 -20,458,000 655,000 -57,247,000 -36,737,000 -296,894,000 -13,720,000 
      income tax benefit
    		331,000 -62,000 -196,000 -1,757,000 590,000 -417,000 133,000 -267,000 -1,210,000 1,759,000 -572,000 -559,000 -580,000 71,000 -179,000 -256,000 -435,000 -16,000 
      income from continuing operations
    		-110,207,000 -104,370,000 -1,888,000 -106,430,000 -116,432,000 -30,662,000 3,247,000 -162,934,000 -31,483,000 15,959,000 -56,514,000 -30,503,000 -21,038,000 726,000 -57,426,000 -36,993,000 -297,329,000 -13,736,000 
      discontinued operations:
    		                  
      income before gain on sales
    		   -425,250 -1,183,000  -518,000            
      adjustments on sale of assets
    		  14,000,000                
      total discontinued operations
    		  14,000,000 640,000 -1,183,000  -9,281,000    -35,000 -236,000 307,000 429,000 689,000 1,035,000 -1,612,000 -1,415,000 
      net income
    		-110,207,000 -104,370,000 12,112,000 -105,790,000 -117,615,000 -30,662,000 -6,034,000 -230,484,000 -31,483,000 15,959,000 -56,549,000 -30,739,000 -20,731,000 1,155,000 -56,737,000 -35,958,000 -298,941,000 -15,151,000 
      yoy
    		-6.30% 240.39% -300.73% -54.10% 273.58% -292.13% -89.33% 649.81% 51.86% 1281.73% -0.33% -14.51% -93.07% -107.62%     
      qoq
    		5.59% -961.71% -111.45% -10.05% 283.59% 408.15% -97.38% 632.09% -297.27% -128.22% 83.96% 48.28% -1894.89% -102.04% 57.79% -87.97% 1873.08%  
      net income margin %
    		-7.68% -7.48% 0.79% -6.95% -8.11% -2.07% -0.38% -28.26% -2.59% 1.40% -8.20% -4.42% -3.09% 0.18% -12.26% -7.84% -59.91% -3.67% 
      noncontrolling interests’ share in (earnings) loss
    		     -20,000 -30,000 51,000 47,000 63,000 83,000 71,000 82,000 75,000 16,000 115,000 96,000  
      net income attributable to common shares
    		-110,207,000 -104,370,000 12,112,000 -105,790,000 -117,615,000 -30,682,000 -6,064,000 -230,433,000 -31,436,000 16,022,000 -56,466,000 -30,668,000 -20,649,000 1,230,000 -56,721,000 -35,843,000 -298,845,000 -15,078,000 
      net income per common share, basic and diluted
    		                  
      continuing operations
    		-270 -250  -260 -290 -70 10 -400 -80 40 -140 -70 -50  -140 -90 -790 -40 
      discontinued operations
    		  30 10   -20        -2.5   -10 
      weighted-average shares outstanding
    		                  
      basic and diluted
    		414,465,000 413,836,000                 
      weighted-average shares outstanding – basic and diluted
    		  412,936,000                
      gain on sales of assets
    		      -8,763,000            
      weighted-average shares outstanding
    		                  
      basic
    		    411,591,000 411,271,000 408,938,000  405,787,000 413,136,000    401,964,000     
      diluted
    		    411,591,000 411,271,000 413,437,000  405,787,000 426,586,000    424,065,000     
      gain on lease terminations
    		            -5,458,000      
      weighted-average shares outstanding, basic and diluted
    		   410,966,000    408,917,000   408,154,000 411,065,000 407,339,000  372,931,000 391,229,000 377,445,000 325,659,000 
      stock-based compensation expense
    		              71,995,000 11,960,000 274,548,000  
      noncontrolling interests’ share in earnings
    		                 73,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.